HEADER TRANSFERASE 10-MAR-15 5AM7 TITLE FGFR1 MUTANT WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 458-765; COMPND 5 SYNONYM: FGFR-1, BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1, BFGFR, COMPND 6 BFGF-R-1, FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, PROTO-ONCOGENE C- COMPND 7 FGR, FIBROBLAST GROWTH FACTOR 1; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: C41 LAMBDA 37; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PJ821 KEYWDS TRANSFERASE, FGFR, CANCER, DOVITINIB, TKI258, GATEKEEPER, GATE KEEPER EXPDTA X-RAY DIFFRACTION AUTHOR T.D.BUNNEY,S.WAN,N.THIYAGARAJAN,L.SUTTO,S.V.WILLIAMS,P.ASHFORD, AUTHOR 2 H.KOSS,M.A.KNOWLES,F.L.GERVASIO,P.V.COVENEY,M.KATAN REVDAT 3 10-JAN-24 5AM7 1 REMARK REVDAT 2 01-JUL-15 5AM7 1 JRNL REVDAT 1 18-MAR-15 5AM7 0 SPRSDE 18-MAR-15 5AM7 4UX0 JRNL AUTH T.BUNNEY,S.WAN,N.THIYAGARAJAN,L.SUTTO,S.V.WILLIAMS, JRNL AUTH 2 P.ASHFORD,H.KOSS,M.A.KNOWLES,F.L.GERVASIO,P.V.COVENEY, JRNL AUTH 3 M.KATAN JRNL TITL THE EFFECT OF MUTATIONS ON DRUG SENSITIVITY AND KINASE JRNL TITL 2 ACTIVITY OF FIBROBLAST GROWTH FACTOR RECEPTORS: A COMBINED JRNL TITL 3 EXPERIMENTAL AND THEORETICAL STUDY JRNL REF EBIOMEDICINE V. 2 194 2015 JRNL REFN ESSN 2352-3964 JRNL PMID 26097890 JRNL DOI 10.1016/J.EBIOM.2015.02.009 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.92 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.7 REMARK 3 NUMBER OF REFLECTIONS : 44767 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2256 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.9206 - 4.9236 0.99 3320 155 0.1609 0.2160 REMARK 3 2 4.9236 - 3.9111 0.99 3201 178 0.1449 0.2004 REMARK 3 3 3.9111 - 3.4176 0.97 3115 181 0.1725 0.2204 REMARK 3 4 3.4176 - 3.1055 0.99 3189 184 0.2023 0.2508 REMARK 3 5 3.1055 - 2.8831 1.00 3227 150 0.2235 0.2822 REMARK 3 6 2.8831 - 2.7133 1.00 3208 161 0.2254 0.2687 REMARK 3 7 2.7133 - 2.5775 1.00 3210 175 0.2263 0.2758 REMARK 3 8 2.5775 - 2.4654 1.00 3187 181 0.2288 0.2916 REMARK 3 9 2.4654 - 2.3705 1.00 3170 180 0.2258 0.2612 REMARK 3 10 2.3705 - 2.2887 0.95 3090 126 0.2330 0.2930 REMARK 3 11 2.2887 - 2.2172 0.74 2337 127 0.4195 0.5931 REMARK 3 12 2.2172 - 2.1538 0.74 2325 164 0.2542 0.3294 REMARK 3 13 2.1538 - 2.0971 0.62 2011 102 0.2442 0.2869 REMARK 3 14 2.0971 - 2.0460 0.52 1639 76 0.2761 0.3368 REMARK 3 15 2.0460 - 1.9995 0.43 1358 78 0.2865 0.3315 REMARK 3 16 1.9995 - 1.9570 0.29 924 38 0.3031 0.3942 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.920 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.05 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4795 REMARK 3 ANGLE : 1.315 6482 REMARK 3 CHIRALITY : 0.057 705 REMARK 3 PLANARITY : 0.007 822 REMARK 3 DIHEDRAL : 14.697 1838 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 226.9365 -11.1503 28.7110 REMARK 3 T TENSOR REMARK 3 T11: 0.1807 T22: 0.2663 REMARK 3 T33: 0.2535 T12: -0.0032 REMARK 3 T13: 0.0130 T23: -0.0327 REMARK 3 L TENSOR REMARK 3 L11: 0.0410 L22: 0.3973 REMARK 3 L33: 0.8148 L12: 0.0476 REMARK 3 L13: 0.1281 L23: -0.3519 REMARK 3 S TENSOR REMARK 3 S11: 0.0132 S12: 0.0160 S13: -0.0450 REMARK 3 S21: 0.0562 S22: -0.0376 S23: -0.0267 REMARK 3 S31: -0.0295 S32: 0.0442 S33: 0.0243 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5AM7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1290063274. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45034 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 28.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.2 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 29.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4UWY REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 5K MME, 0.1 M TRIS, PH 7.5, REMARK 280 0.2 M (NH4)2SO4, PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.30300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.91750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.30300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.91750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 456 REMARK 465 VAL A 457 REMARK 465 GLY A 487 REMARK 465 ALA A 488 REMARK 465 PHE A 489 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 GLU A 765 REMARK 465 MET B 456 REMARK 465 VAL B 457 REMARK 465 GLY B 487 REMARK 465 ALA B 488 REMARK 465 PHE B 489 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 ASP B 652 REMARK 465 ASN B 763 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 646 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CD PRO B 579 O HOH B 2041 1.95 REMARK 500 O HOH A 2094 O HOH A 2099 2.13 REMARK 500 NE2 GLN A 764 O HOH A 2128 2.15 REMARK 500 OH TYR A 654 OE2 GLU A 707 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 579 CA - N - CD ANGL. DEV. = -12.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 460 106.55 -55.37 REMARK 500 TYR A 463 -163.07 -102.92 REMARK 500 GLU A 592 -156.13 -130.32 REMARK 500 ARG A 622 -13.87 81.66 REMARK 500 ASP A 623 42.35 -142.20 REMARK 500 THR A 657 -169.83 -74.90 REMARK 500 CYS A 725 129.05 179.50 REMARK 500 LYS B 502 40.77 -83.02 REMARK 500 PRO B 578 170.95 -58.46 REMARK 500 GLU B 592 -156.35 -138.06 REMARK 500 GLU B 593 106.78 31.56 REMARK 500 ARG B 622 -12.60 79.13 REMARK 500 ASP B 623 40.52 -141.87 REMARK 500 ASN B 659 -31.57 -163.94 REMARK 500 CYS B 725 129.64 -178.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 763 GLN A 764 -149.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2074 DISTANCE = 6.94 ANGSTROMS REMARK 525 HOH B2088 DISTANCE = 7.70 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 38O A 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 38O B 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1765 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1766 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1763 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AM6 RELATED DB: PDB REMARK 900 NATIVE FGFR1 WITH AN INHIBITOR DBREF 5AM7 A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 5AM7 B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 5AM7 MET A 456 UNP P11362 EXPRESSION TAG SEQADV 5AM7 VAL A 457 UNP P11362 EXPRESSION TAG SEQADV 5AM7 ALA A 488 UNP P11362 CYS 488 CONFLICT SEQADV 5AM7 MET A 561 UNP P11362 VAL 561 ENGINEERED MUTATION SEQADV 5AM7 SER A 584 UNP P11362 CYS 584 CONFLICT SEQADV 5AM7 MET B 456 UNP P11362 EXPRESSION TAG SEQADV 5AM7 VAL B 457 UNP P11362 EXPRESSION TAG SEQADV 5AM7 ALA B 488 UNP P11362 CYS 488 CONFLICT SEQADV 5AM7 MET B 561 UNP P11362 VAL 561 ENGINEERED MUTATION SEQADV 5AM7 SER B 584 UNP P11362 CYS 584 CONFLICT SEQRES 1 A 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 A 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 A 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 A 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 A 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 A 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 A 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 A 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 A 310 ILE MET GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 A 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 A 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 A 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 A 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 A 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 A 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 A 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 A 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 A 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 A 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 A 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 A 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 A 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 A 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 A 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 B 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 B 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 B 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 B 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 B 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 B 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 B 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 B 310 ILE MET GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 B 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 B 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 B 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 B 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 B 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 B 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 B 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 B 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 B 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 B 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 B 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 B 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 B 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 B 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 B 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET 38O A1000 29 HET CL A1765 1 HET CL A1766 1 HET 38O B1000 29 HET CL B1763 1 HETNAM 38O 4-AMINO-5-FLUORO-3-[5-(4-METHYLPIPERAZIN-1-YL)-1H- HETNAM 2 38O BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE HETNAM CL CHLORIDE ION HETSYN 38O DOVITINIB FORMUL 3 38O 2(C21 H21 F N6 O) FORMUL 4 CL 3(CL 1-) FORMUL 8 HOH *217(H2 O) HELIX 1 1 PRO A 474 ASP A 476 5 3 HELIX 2 2 THR A 521 GLY A 539 1 19 HELIX 3 3 ASN A 568 ALA A 575 1 8 HELIX 4 4 SER A 596 LYS A 617 1 22 HELIX 5 5 ALA A 625 ARG A 627 5 3 HELIX 6 6 ASP A 647 ILE A 651 5 5 HELIX 7 7 LEU A 662 MET A 667 5 6 HELIX 8 8 ALA A 668 ARG A 675 1 8 HELIX 9 9 THR A 678 THR A 695 1 18 HELIX 10 10 PRO A 705 GLU A 715 1 11 HELIX 11 11 THR A 726 TRP A 737 1 12 HELIX 12 12 VAL A 740 ARG A 744 5 5 HELIX 13 13 THR A 746 THR A 761 1 16 HELIX 14 14 PRO B 474 ASP B 476 5 3 HELIX 15 15 THR B 521 GLY B 539 1 19 HELIX 16 16 ASN B 568 ALA B 575 1 8 HELIX 17 17 SER B 596 LYS B 617 1 22 HELIX 18 18 ALA B 625 ARG B 627 5 3 HELIX 19 19 LEU B 662 MET B 667 5 6 HELIX 20 20 ALA B 668 ARG B 675 1 8 HELIX 21 21 THR B 678 THR B 695 1 18 HELIX 22 22 PRO B 705 GLU B 715 1 11 HELIX 23 23 THR B 726 TRP B 737 1 12 HELIX 24 24 VAL B 740 ARG B 744 5 5 HELIX 25 25 THR B 746 LEU B 760 1 15 SHEET 1 AA 5 LEU A 478 GLY A 485 0 SHEET 2 AA 5 GLN A 491 ILE A 498 -1 O VAL A 492 N LEU A 484 SHEET 3 AA 5 VAL A 508 MET A 515 -1 O THR A 509 N ALA A 497 SHEET 4 AA 5 TYR A 558 GLU A 562 -1 O VAL A 559 N LYS A 514 SHEET 5 AA 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AB 2 VAL A 629 VAL A 631 0 SHEET 2 AB 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 BA 5 LEU B 478 GLY B 485 0 SHEET 2 BA 5 GLN B 491 ILE B 498 -1 O VAL B 492 N LEU B 484 SHEET 3 BA 5 VAL B 508 MET B 515 -1 O THR B 509 N ALA B 497 SHEET 4 BA 5 TYR B 558 GLU B 562 -1 O VAL B 559 N LYS B 514 SHEET 5 BA 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 BB 2 VAL B 629 VAL B 631 0 SHEET 2 BB 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 CISPEP 1 VAL A 460 SER A 461 0 -1.49 CISPEP 2 ASN B 659 GLY B 660 0 -14.00 SITE 1 AC1 11 VAL A 492 ALA A 512 ILE A 545 MET A 561 SITE 2 AC1 11 GLU A 562 TYR A 563 ALA A 564 SER A 565 SITE 3 AC1 11 LYS A 566 GLY A 567 LEU A 630 SITE 1 AC2 10 LEU B 484 ALA B 512 ILE B 545 MET B 561 SITE 2 AC2 10 GLU B 562 TYR B 563 ALA B 564 SER B 565 SITE 3 AC2 10 GLY B 567 LEU B 630 SITE 1 AC3 3 ARG A 570 ARG A 627 ARG A 661 SITE 1 AC4 1 LYS A 618 SITE 1 AC5 3 ARG B 570 ARG B 627 ARG B 661 CRYST1 208.606 57.835 65.622 90.00 107.40 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004794 0.000000 0.001502 0.00000 SCALE2 0.000000 0.017291 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015970 0.00000